• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Percent of CDRH intra- and inter-Office eConsults completed on time during the month

Dictionary: CDRH uses the internal expert consultation process to acquire information and analysis on issues related to medical devices. Intra- and inter-office consultations are completed for a variety of work products requiring expertise within and across CDRH offices, including premarket device submissions, post-approval studies, and compliance and enforcement actions. Inter-office eConsults are used to facilitate the exchange of scientific information and staff expertise across CDRH, critical to making well-supported regulatory decisions. eConsult is the system CDRH uses to manage and monitor expert consult requests.

Information is current as of September 30, 2013

Fiscal Year - 2012

Skip graphic and jump to text data

TimeTargetPercent
Oct 20118587
Nov 20118589
Dec 20118588
Jan 20128591
Feb 20128588
Mar 20128590
Apr 20128588
May 20128591
Jun 20128590
Jul 20128591
Aug 20128591
Sep 20128589

FY 2012 Overall: 90%

Number of CDRH intra- and inter-Office eConsults completed on time during the month

Fiscal Year - 2012
Skip graphic and jump to text data.

TimeTargetNumber
Oct 2011N/A1,401
Nov 2011N/A1,517
Dec 2011N/A1,424
Jan 2012N/A1,515
Feb 2012N/A1,656
Mar 2012N/A1,924
Apr 2012N/A1,673
May 2012N/A1,746
Jun 2012N/A1,772
Jul 2012N/A1,820
Aug 2012N/A2,053
Sep 2012N/A1,455

FY 2012 Total: 19,956

Total number of CDRH intra- and inter-Office eConsults completed during the month

Fiscal Year - 2012
Skip graphic and jump to text data.

TimeTargetNumber
Oct 2011N/A1,602
Nov 2011N/A1,712
Dec 2011N/A1,622
Jan 2012N/A1,656
Feb 2012N/A1,892
Mar 2012N/A2,144
Apr 2012N/A1,893
May 2012N/A1,909
Jun 2012N/A1,964
Jul 2012N/A1,994
Aug 2012N/A2,265
Sep 2012N/A1,642

FY 2012 Total: 22,295

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.